PODCAST | Efficient Communication Reduces Regulatory Uncertainty — CBER Director, US FDA

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA), speaks with Chris Houchin, Partner at Guidehouse, in a video interview about leveraging AI at the agency, developments in data driven healthcare, and improving communication regarding frontier topics like explainability, data integrity, bias, and data security.